ADJUVANT BEVACIZUMAB IS SAFE TREATMENT FOR MELANOMA PATIENTS AT HIGH RISK OF RECURRENCE
Biswas S. et al, (2008), ANNALS OF ONCOLOGY, 19, 245 - 245
FACTORS PREDICTING OUTCOME FOR ADVANCED GASTROESOPHAGEAL CANCER IN ELDERLY PATIENTS RECEIVING CHEMOTHERAPY: A RETROSPECTIVE ANALYSIS
Lord SR. et al, (2008), ANNALS OF ONCOLOGY, 19, 210 - 210
IS CHEMOTHERAPY RE-CHALLENGE WORTHWHILE IN PATIENTS WITH RECURRENT GASTROESOPHAGEAL CANCER?
Hall PS. et al, (2008), ANNALS OF ONCOLOGY, 19, 171 - 171
Fc receptors in immune thrombocytopenias: a target for immunomodulation?
Psaila B. and Bussel JB., (2008), J Clin Invest, 118, 2677 - 2681
Fc receptors in immune thrombocytopenias: a target for immunomodulation?
Psaila B. and Bussel JB., (2008), JOURNAL OF CLINICAL INVESTIGATION, 118, 2677 - 2681
High-intensity focused ultrasound ablation of liver tumours: can radiological assessment predict the histological response?
Leslie TA. et al, (2008), Br J Radiol, 81, 564 - 571
EFFICACY AND SAFETY OF REPEATED INTERMITTENT TREATMENT WITH ELTROMBOPAG IN PATIENTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)
Psaila B. et al, (2008), HAEMATOLOGICA, 93, 120 - 120
Phase I pharmacokinetic and pharmacodynamic study of the prenyl transferase inhibitor AZD3409 in patients with advanced cancer.
Appels NMGM. et al, (2008), Br J Cancer, 98, 1951 - 1958
EFFICACY AND SAFETY OF REPEATED INTERMITTENT TREATMENT WITH ELTROMBOPAG IN PATIENTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)
Psaila B. et al, (2008), HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 93, 120 - 120
Future directions in the management of epithelial ovarian cancer.
Blagden S. and Gabra H., (2008), Future Oncol, 4, 403 - 411
A phase II study of PTK787 in metastatic melanoma patients.
Corrie P. et al, (2008), J Clin Oncol, 26
A phase II study of PTK787 in metastatic melanoma patients
Corrie P. et al, (2008), JOURNAL OF CLINICAL ONCOLOGY, 26
A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer.
Khan OA. et al, (2008), Br J Cancer, 98, 1614 - 1618
AZD6244 (ARRY-142886) vs temozolomide (TMZ) in patients (pts) with advanced melanoma: An open-label, randomized, multicenter, phase II study.
Dummer R. et al, (2008), J Clin Oncol, 26
AZD6244 (ARRY-142886) vs temozolomide (TMZ) in patients (pts) with advanced melanoma: An open-label, randomized, multicenter, phase II study
Dummer R. et al, (2008), JOURNAL OF CLINICAL ONCOLOGY, 26
Inhibition of O-6-methylguanine DNA methyltransferase (MGMT) in solid tumors by lomeguatrib
Sabharwal A. et al, (2008), JOURNAL OF CLINICAL ONCOLOGY, 26
Nemorubicin hydrochloride (nemorubicin) in combination with cisplatin (cDDP): Phase I in patients (pts) with hepatocellular carcinoma (HCC)
Fiore F. et al, (2008), JOURNAL OF CLINICAL ONCOLOGY, 26
Nemorubicin hydrochloride (nemorubicin) in combination with cisplatin (cDDP): Phase I in patients (pts) with hepatocellular carcinoma (HCC).
Fiore F. et al, (2008), J Clin Oncol, 26
Preliminary results of a Cancer Research UK phase I trial combining the dinitrobenzamide prodrug CB1954 (tretazicar) and the NQO2 substrate EP-0152R (caricotamide)
Sarker D. et al, (2008), JOURNAL OF CLINICAL ONCOLOGY, 26
The effect of food on the single dose pharmacokinetics of cediranib
Jayson GC. et al, (2008), JOURNAL OF CLINICAL ONCOLOGY, 26